|
Volumn 56, Issue 4, 2002, Pages 267-271
|
14. Breast cancer prevention
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
ARZOXIFENE;
BISPHOSPHONIC ACID DERIVATIVE;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
ESTROGEN RECEPTOR;
GONADORELIN DERIVATIVE;
LETROZOLE;
ORAL CONTRACEPTIVE AGENT;
PLACEBO;
POLYAMINE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTEIN TYROSINE KINASE INHIBITOR;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
ADULT;
AGING;
ALCOHOL CONSUMPTION;
ARTICLE;
BREAST CANCER;
CANCER INCIDENCE;
CANCER RISK;
CHEMOPROPHYLAXIS;
CONTROLLED STUDY;
DIET;
EXERCISE;
FEMALE;
GENE MUTATION;
GENETIC SUSCEPTIBILITY;
HORMONE DETERMINATION;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
LACTATION;
LIFESPAN;
LIFESTYLE;
MAMMOGRAPHY;
MASTECTOMY;
MATERNAL AGE;
MENSTRUAL IRREGULARITY;
MENSTRUATION;
MOOD;
NAUSEA;
OBESITY;
PREGNANCY;
PRIORITY JOURNAL;
SIDE EFFECT;
VAGINA DISCHARGE;
WEIGHT GAIN;
BREAST NEOPLASMS;
EUROPE;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
HUMANS;
ITALY;
LIFE STYLE;
MASS SCREENING;
MUTATION;
RANDOMIZED CONTROLLED TRIALS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
|
EID: 0036279218
PISSN: 13685031
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (29)
|